JPWO2021129658A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021129658A5 JPWO2021129658A5 JP2022538928A JP2022538928A JPWO2021129658A5 JP WO2021129658 A5 JPWO2021129658 A5 JP WO2021129658A5 JP 2022538928 A JP2022538928 A JP 2022538928A JP 2022538928 A JP2022538928 A JP 2022538928A JP WO2021129658 A5 JPWO2021129658 A5 JP WO2021129658A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024127939A JP2024167222A (ja) | 2019-12-24 | 2024-08-02 | 加齢黄斑変性の治療における融合タンパク質の使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911346311.2 | 2019-12-24 | ||
| CN201911346311 | 2019-12-24 | ||
| CN202011441025 | 2020-12-11 | ||
| CN202011441025.7 | 2020-12-11 | ||
| PCT/CN2020/138598 WO2021129658A1 (zh) | 2019-12-24 | 2020-12-23 | 融合蛋白在治疗年龄相关性黄斑变性中的应用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024127939A Division JP2024167222A (ja) | 2019-12-24 | 2024-08-02 | 加齢黄斑変性の治療における融合タンパク質の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509880A JP2023509880A (ja) | 2023-03-10 |
| JP2023509880A5 JP2023509880A5 (https=) | 2023-06-05 |
| JPWO2021129658A5 true JPWO2021129658A5 (https=) | 2023-06-05 |
Family
ID=76575187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538928A Pending JP2023509880A (ja) | 2019-12-24 | 2020-12-23 | 加齢黄斑変性の治療における融合タンパク質の使用 |
| JP2024127939A Pending JP2024167222A (ja) | 2019-12-24 | 2024-08-02 | 加齢黄斑変性の治療における融合タンパク質の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024127939A Pending JP2024167222A (ja) | 2019-12-24 | 2024-08-02 | 加齢黄斑変性の治療における融合タンパク質の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230056821A1 (https=) |
| EP (1) | EP4082559A4 (https=) |
| JP (2) | JP2023509880A (https=) |
| CN (2) | CN118750581A (https=) |
| AU (2) | AU2020414152B2 (https=) |
| CA (1) | CA3165887A1 (https=) |
| TW (2) | TWI879855B (https=) |
| WO (1) | WO2021129658A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| CN117467025B (zh) * | 2023-12-28 | 2024-04-16 | 上海鼎新基因科技有限公司 | 一种抗vegf和补体双功能融合蛋白及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014013205A2 (pt) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit |
| CN104940926B (zh) * | 2014-09-25 | 2017-09-22 | 信达生物制药(苏州)有限公司 | 重组融合蛋白制剂 |
| CN105435222B (zh) * | 2014-09-25 | 2018-05-29 | 信达生物制药(苏州)有限公司 | 重组融合蛋白制剂 |
-
2020
- 2020-12-23 CN CN202410790623.7A patent/CN118750581A/zh active Pending
- 2020-12-23 US US17/788,181 patent/US20230056821A1/en active Pending
- 2020-12-23 AU AU2020414152A patent/AU2020414152B2/en active Active
- 2020-12-23 TW TW109145708A patent/TWI879855B/zh active
- 2020-12-23 TW TW113142581A patent/TW202525865A/zh unknown
- 2020-12-23 CA CA3165887A patent/CA3165887A1/en active Pending
- 2020-12-23 CN CN202080090126.6A patent/CN114867489A/zh active Pending
- 2020-12-23 WO PCT/CN2020/138598 patent/WO2021129658A1/zh not_active Ceased
- 2020-12-23 JP JP2022538928A patent/JP2023509880A/ja active Pending
- 2020-12-23 EP EP20904512.9A patent/EP4082559A4/en active Pending
-
2024
- 2024-08-02 JP JP2024127939A patent/JP2024167222A/ja active Pending
-
2025
- 2025-05-09 AU AU2025203373A patent/AU2025203373A1/en active Pending